Evidence map›Paper›PMID 28696308›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

tsRNA signatures in cancer.

Veronica Balatti, Giovanni Nigita, Dario Veneziano, Alessandra Drusco, Gary S Stein, Terri L Messier, Nicholas H Farina, Jane B Lian, Luisa Tomasello, Chang-Gong Liu and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 194 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
194citing papers in PubMed, 3 pooled it
7.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

194 citing papers in PubMed, 3 syntheses or guidelines pooled it, 287 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Dissecting the small RNA code of inflammatory bowel disease.Molecular medicine (Cambridge, Mass.) · 2026
    Article
  15. Review
  16. Article
  17. Article
  18. Unlocking the role of tRNA-derived fragments in shaping breast cancer signaling.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  19. Article
  20. Review

134 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 2 countries.

Veronica BalattiDepartment of Cancer Biology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210.
Giovanni NigitaDepartment of Cancer Biology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210.
Dario VenezianoDepartment of Cancer Biology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210.
Alessandra DruscoDepartment of Cancer Biology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210.
Gary S SteinDepartment of Biochemistry, University of Vermont College of Medicine, Burlington, VT 05405.
Terri L MessierDepartment of Biochemistry, University of Vermont College of Medicine, Burlington, VT 05405.
Nicholas H FarinaDepartment of Biochemistry, University of Vermont College of Medicine, Burlington, VT 05405.
Jane B LianDepartment of Biochemistry, University of Vermont College of Medicine, Burlington, VT 05405.
Luisa TomaselloDepartment of Cancer Biology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210.
Chang-Gong LiuMD Anderson Cancer Center, Houston, TX 77030.
Alexey PalamarchukDepartment of Cancer Biology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210.
Jonathan R HartDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Catherine BellDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Mariantonia CarosiIstituto di Ricovero e Cura a Carattere Scientifico, Regina Elena National Cancer Institute, 00144 Rome, Italy.
Edoardo PescarmonaIstituto di Ricovero e Cura a Carattere Scientifico, Regina Elena National Cancer Institute, 00144 Rome, Italy.
Letizia PerracchioIstituto di Ricovero e Cura a Carattere Scientifico, Regina Elena National Cancer Institute, 00144 Rome, Italy.
Maria DiodoroIstituto di Ricovero e Cura a Carattere Scientifico, Regina Elena National Cancer Institute, 00144 Rome, Italy.
Andrea RussoIstituto di Ricovero e Cura a Carattere Scientifico, Regina Elena National Cancer Institute, 00144 Rome, Italy.
Anna AntenucciIstituto di Ricovero e Cura a Carattere Scientifico, Regina Elena National Cancer Institute, 00144 Rome, Italy.
Paolo ViscaIstituto di Ricovero e Cura a Carattere Scientifico, Regina Elena National Cancer Institute, 00144 Rome, Italy.
Antonio CiardiUniversita' Di Roma La Sapienza, 00185 Rome, Italy.
Curtis C HarrisLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Peter K VogtDepartment of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Yuri PekarskyDepartment of Cancer Biology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210; Pekarsky.yuri@osumc.edu carlo.croce@osumc.edu.
Carlo M CroceDepartment of Cancer Biology and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210; Pekarsky.yuri@osumc.edu carlo.croce@osumc.edu.
The Ohio State University · USUniversity of Vermont · USScripps Research Institute · USCenter for Cancer Research · USSapienza University of Rome · ITThe University of Texas MD Anderson Cancer Center · US

Funding

Precision Medicine of CancerZIABC011492 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2013 to 2025
$23.2M
SUBNUCLEAR TARGETING OF TRANSCRIPTION FACTORSP01CA082834 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STEIN, GARY S. · 2001 to 2015
$18.4M
Cancer genes: translating basics to applicationsR35CA197582 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI VOGT, PETER K · 2016 to 2022
$7.8M
Cancer Gene Discovery to Identify Targetable TargetsR35CA197706 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M · 2015 to 2021
$6.4M
Vermont Breast Cancer Molecular Characterization LaboratoryU01CA196383 · NCI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI SPRAGUE, BRIAN L, STEIN, JANET L · 2015 to 2020
$5.4M
Identifying non-coding RNAs for early detection and prevention of lung cancerU01CA166905 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M, PASS, HARVEY IRA · 2013 to 2017
$4.5M
Molecular Mechanisms of Cachexia in Lung CancerR01CA190740 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M, NANASINKAM, SERGE PATRICK · 2015 to 2019
$2.1M
NCI NIH HHS P01 CA082834NCI NIH HHS R01 CA190740NCI NIH HHS R35 CA197582NCI NIH HHS R35 CA197706NCI NIH HHS U01 CA166905NCI NIH HHS U01 CA196383
6 · The paper itself

Abstract

Small, noncoding RNAs are short untranslated RNA molecules, some of which have been associated with cancer development. Recently we showed that a class of small RNAs generated during the maturation process of tRNAs (tRNA-derived small RNAs, hereafter "tsRNAs") is dysregulated in cancer. Specifically, we uncovered tsRNA signatures in chronic lymphocytic leukemia and lung cancer and demonstrated that the

Indexed as

A549 CellsCase-Control StudiesHEK293 CellsHumansNeoplasmsOncogenesRNA, Small UntranslatedRNA, Small UntranslatedncRNAtDRtRFtRNA fragmentstsRNA

Identifiers

PMID28696308
PMCPMC5544330
OpenAlexW2734686459

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.